Monoclonal antibodies (mAbs) have emerged as a cornerstone in biopharmaceuticals, offering targeted and effective treatments for various diseases. This blog post explores the latest innovations in monoclonal antibody therapy developed by Antagen Pharmaceuticals Inc. Discover how mAbs are designed, their mechanisms of action, and their applications in treating infectious diseases, cancer, and autoimmune disorders. Explore the potential of monoclonal antibody therapy to transform patient care and improve outcomes in the healthcare landscape.